Penkrofton tablets 0.2 g

Roman name

Tabulettae Pencroftoni 0.2 g

The composition and the form of

1 tablet contains mifepristone 0.2 g; Banks in dark glasses to 3 or 30 pcs. , in one box Bank.

Of drugs

Antiprogestagennoe. Prevents progesterone binding with the receptor.

Pharmacokinetics

Quickly absorbed and creates maximum concentration in plasma. T_1/2 - 1830

Indications

Medically interrupt uterine pregnancy in the early stages (up to 42 days).

Contraindications

Hypersensitivity, pregnancy (ectopic or via clinical research, or contain more than 42 days after the cessation of menstruation, as well as having in the face of uterine or hormonal contraceptives); Waginita, mioma or a scar on the uterus and the paucity napochechnikov violation hemostasis, anaemia.

Side-Effects

Breeding bleeding, discomfort and pain at the bottom of the stomach, uterus infection and urinary tract. The weakness, headache, dizziness, hyperthermia, nausea, vomiting, diarrhoea.

Specific guidance

Apply only in a medical establishment.

Overdosing

Under napochechnikov.

Precautions

It should not be combined with NPVS. Be wary appointed in cases of chronic obstructive lung diseases, kidney or liver failure, pathology cardiovascular system.

Dosing and Administration

Inside, one 600 mg. By the 14th day abortion to be confirmed by clinical examination, ultrasound, the level Chemical in blood. In the absence of the impact of drug use from the 14th day (incomplete abortions or continued pregnancy) wakuum-aspiratia out.

Directory → Hormones and their antagonists → Estrogens, gestagena; Their homologues and antagonists → Penkrofton tablets 0.2 g